#2X1 - Abivax SA
Abivax Announces Launch of Public Offering
PARIS, France, July 23, 2025 - 10:15 p.m. (CEST) - Abivax SA (Euronext Paris: <FR0012333284> - ABVX) ("Abivax" or the "
Company"), a clinical-stage biotechnology company focused on developing therapeutics that harness the body's...